Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$65.94 - $99.04 $285,652 - $429,041
4,332 Added 103.19%
8,530 $581,000
Q2 2023

Aug 11, 2023

SELL
$62.68 - $95.05 $386,923 - $586,743
-6,173 Reduced 59.52%
4,198 $394,000
Q1 2023

May 12, 2023

BUY
$47.19 - $70.77 $143,740 - $215,565
3,046 Added 41.58%
10,371 $703,000
Q4 2022

Feb 13, 2023

BUY
$30.35 - $53.15 $222,313 - $389,323
7,325 New
7,325 $362,000
Q2 2022

Aug 15, 2022

BUY
$35.61 - $76.23 $587,315 - $1.26 Million
16,493 Added 160.88%
26,745 $1.05 Million
Q1 2022

May 16, 2022

BUY
$57.56 - $82.54 $590,105 - $846,200
10,252 New
10,252 $717,000
Q4 2021

Feb 14, 2022

SELL
$72.5 - $100.68 $360,107 - $500,077
-4,967 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$90.24 - $124.05 $448,222 - $616,156
4,967 New
4,967 $474,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.61B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Echo Street Capital Management LLC Portfolio

Follow Echo Street Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Echo Street Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Echo Street Capital Management LLC with notifications on news.